calendar
18,993 catalysts · 18,987 approval · 5,347 phase readout · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma
next 91 dayslessmore
MonWedFri
18,993 catalysts · 18,987 approval · 5,347 phase readout · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: AZURITY. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: INGENUS PHARMS NJ. Form: TABLET. Route: ORAL
Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IMPAX LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL